Disclosure Panels Details Page

Melanoma Panel - Disclosures as of 05/04/2012

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Robert Andtbacka MD None Amgen Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
None None NA
Christopher Anker MD None None None None NA
Christopher Bichakjian MD None None None None NA -
William Carson III MD None None Castle Bioscience
Dragonfly Therapeutics
None NA -
Daniel Coit MD, FACS None None None None NA
Adil Daud MD Abbott Laboratories
GlaxoSmithKline
Merck & Co., Inc.
Pfizer Inc.
Roche Laboratories, Inc.
Schering-Plough Corporation
Wyeth Pharmaceuticals
Amgen Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Oncosec
Serono
None Oncosec NA
Dominick DiMaio MD None None None None NA -
Martin Fleming MD, FACS None None None None NA
Lauren Gallagher None None None None None
Kristina Gregory MSN, RN, OCN None None None None NA -
Valerie Guild MBA None None None None NA
Allan Halpern MD Janssen Research & Development, LLC
Quintiles
Caliber ID
Canfield Scientific
DermTech
Emerald Medical Applications
Novartis Pharmaceuticals Corporation
SciBase
None None None
Maria Ho None None None None NA
F. Stephen Hodi MD Bristol-Myers Squibb Company
Genentech, Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Amgen Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Amgen Inc.
Bristol-Myers Squibb Company
Genentech, Inc.
GlaxoSmithKline
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Bristol-Myers Squibb Company None -
Mark Kelley MD, MMHC, FACS GlaxoSmithKline None None None NA
Nikhil Khushalani MD AstraZeneca Pharmaceuticals LP
Bristol-Myers Squibb Company
Celgene Corporation
CytRx
Eisai Inc.
Genentech, Inc.
Merck & Co., Inc.
NCCN (Grant funded clinical trials from the ORP)
Pfizer Inc.
Threshold
Tracon
Amgen Inc.
Bristol-Myers Squibb Company
Prometheus None NA
Ragini Kudchadkar Bristol-Myers Squibb Company
Genentech, Inc.
GlaxoSmithKline
Genentech, Inc. None None NA -
Julie Lange MD, ScM None None None None NA -
Anne Lind MD None None None None NA
Mary Martini MD None dove- unilever None None None
Joan McClure MS None None None None NA
Nicole McMillian MS None None None None NA
Anthony Olszanski MD, RPh None Bristol-Myers Squibb Company
Merck & Co., Inc.
sanofi-aventis U.S.
None None NA
Scott Pruitt MD, PhD None None None None NA -
Merrick Ross MD Amgen Inc. Amgen Inc.
Merck & Co., Inc.
Amgen Inc. None NA
Susan Swetter MD None None None None NA
Kenneth Tanabe MD NIH/DCP
Phase I clinical trial of oncolytic virus
Advance Medical
American Cancer Society
Best Doctors
Cancer Experts Now
Helix12
Leidos
UpToDate
None None NA -
John Thompson MD Calithera Pharmaceuticals AVEO Pharmaceuticals, Inc.
Iovance pharmaceuticals
Regeneron Pharmaceuticals, Inc.
None None NA
Vijay Trisal MD None None None None None -
Marshall Urist MD None None None None NA